Agios Pharmaceuticals, Inc. -
Common Stock (AGIO) [ST]
ARIA INTELLIGENCE BRIEF
Disclosure filings show two members of Congress — Gil Cisneros and Josh Gottheimer — have reported a combined five trades in this Health Care sector security, all of which are purchases with no sales disclosed, spanning from January 2024 through March 2026. The activity is confined to these two members with no bipartisan co-trading cluster recorded, reflecting a narrow congressional footprint in the name. Separately, one executive-branch official has disclosed one transaction in the same security, representing an independent overlap in the public filing record across branches. The purchase-only posture and multi-year timeframe characterize the disclosed activity in aggregate.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
5
BUYS
5
SELLS
0
MEMBERS
2
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+5.41%
vs SPY benchmark
AGIO timeline6 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Lander, Eric S Director | Jun 10, 21 | SELL | $15K–$50K |
5 trades
Congressional trading data from STOCK Act filings. Not investment advice.